<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0187-0173</journal-id>
<journal-title><![CDATA[Sociológica (México)]]></journal-title>
<abbrev-journal-title><![CDATA[Sociológica (Méx.)]]></abbrev-journal-title>
<issn>0187-0173</issn>
<publisher>
<publisher-name><![CDATA[Universidad Autónoma Metropolitana, División de Ciencias Sociales y Humanidades]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0187-01732021000300183</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Propiedad intelectual en época del SARS-CoV-2 (COVID-19). La disyuntiva entre lo privado y el bienestar social]]></article-title>
<article-title xml:lang="en"><![CDATA[Intellectual Property in the Age of SARS-CoV-2 (Covid-19). The Dilemma between the Private and Social Well-Being]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González Merino]]></surname>
<given-names><![CDATA[Arcelia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castañeda Zavala]]></surname>
<given-names><![CDATA[Yolanda]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Autónoma Metropolitana Departamento de Sociología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Autónoma Metropolitana Departamento de Sociología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>36</volume>
<numero>104</numero>
<fpage>183</fpage>
<lpage>218</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0187-01732021000300183&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0187-01732021000300183&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0187-01732021000300183&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen El objetivo del presente artículo es analizar y cuestionar, desde el concepto de modernidad, cómo el sistema de patentes ha agudizado los impactos tanto social como económico adversos que se han vivido con la pandemia del SARS-CoV-2 desde diciembre de 2019. Se revisa el papel que han jugado las empresas biofarmacéuticas en el mercado internacional de vacunas y del sistema de propiedad intelectual asociado. Finalmente, en el caso específico de México analizaremos la evolución del sistema de propiedad intelectual y cómo la vacunación ha sido un proceso que, si bien ha ido avanzando de acuerdo con los criterios del tipo de sector y edad, va lento, por lo que persisten los contagios y la letalidad, y el interés privado prevalece sobre el bienestar social.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The aim of this article is to use the concept of modernity to analyze and question how the system of patents has sharpened the adverse social and economic impacts of the SARS-CoV-2 pandemic since December 2019. The authors review the role played by bio-pharmaceutical companies in the international vaccine market and the intellectual property system associated with it. Finally, in the specific case of Mexico, they analyze the evolution of the intellectual property system and how vaccination has been a process that, while it has moved ahead using criteria based on sectors and age, continues to be slow, and there fore contagion and death rates continue to exist and private interests continue to prevail over social well-being.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[modernidad]]></kwd>
<kwd lng="es"><![CDATA[Covid-19]]></kwd>
<kwd lng="es"><![CDATA[vacunas]]></kwd>
<kwd lng="es"><![CDATA[patentes]]></kwd>
<kwd lng="es"><![CDATA[bienestar social]]></kwd>
<kwd lng="es"><![CDATA[México]]></kwd>
<kwd lng="en"><![CDATA[modernity]]></kwd>
<kwd lng="en"><![CDATA[Covid-19]]></kwd>
<kwd lng="en"><![CDATA[patents]]></kwd>
<kwd lng="en"><![CDATA[social well-being]]></kwd>
<kwd lng="en"><![CDATA[Mexico]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>ABC</collab>
<source><![CDATA[Cuántos casos de trombos se han relacionado con la vacuna de AstraZeneca]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arista]]></surname>
<given-names><![CDATA[Lidia]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La obesidad es más peligrosa que el coronavirus o el crimen organizado, alertan]]></article-title>
<source><![CDATA[Expansión]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bauman]]></surname>
<given-names><![CDATA[Zygmunt]]></given-names>
</name>
</person-group>
<source><![CDATA[Modernidad líquida]]></source>
<year>2004</year>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Fondo de Cultura Económica]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="">
<collab>BBC (British Broadcasting Corporation)</collab>
<source><![CDATA[Covid: What do We Know About China's Coronavirus Vaccines?]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Becerra]]></surname>
<given-names><![CDATA[Manuel]]></given-names>
</name>
</person-group>
<source><![CDATA[Hacia una política de Estado en materia de propiedad intelectual]]></source>
<year>2011</year>
<publisher-name><![CDATA[Instituto de Investigaciones Jurídicas y Cámara de Diputados]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Becerra]]></surname>
<given-names><![CDATA[Manuel]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Farmacéuticos, propiedad intelectual y derechos humanos. En busca de un equilibrio]]></article-title>
<source><![CDATA[Derecho global. Estudios sobre derecho y justicia]]></source>
<year>2020</year>
<volume>15</volume>
<page-range>143-77</page-range><publisher-name><![CDATA[Universidad de Guadalajara]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beck]]></surname>
<given-names><![CDATA[Ulrich]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La reinvención de la política: hacia una teoría de modernización reflexiva]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Beck]]></surname>
<given-names><![CDATA[Ulrich]]></given-names>
</name>
<name>
<surname><![CDATA[Giddens]]></surname>
<given-names><![CDATA[Antony]]></given-names>
</name>
<name>
<surname><![CDATA[Lash]]></surname>
<given-names><![CDATA[Scott]]></given-names>
</name>
</person-group>
<source><![CDATA[Modernización reflexiva. Política, tradición y estética en el orden social moderno]]></source>
<year>1994</year>
<page-range>13-73</page-range><publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Alianza Universidad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="">
<collab>Cámara de Diputados</collab>
<source><![CDATA[Al declararlos confidenciales, SRE oculta información de contratos con Pfizer para compra de vacunas]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cueni]]></surname>
<given-names><![CDATA[Thomas]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Risk in Suspending Vaccine Patent Rules]]></article-title>
<source><![CDATA[The New York Times]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Drahos]]></surname>
<given-names><![CDATA[Peter]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global Property Rights in Information: The story of TRIPS at the GATT]]></article-title>
<source><![CDATA[Prometheus]]></source>
<year>1995</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-19</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dussel]]></surname>
<given-names><![CDATA[Enrique]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Eurocentrismo y modernidad (Introducción a las lecturas de Frankfurt)]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Beverley]]></surname>
<given-names><![CDATA[John]]></given-names>
</name>
<name>
<surname><![CDATA[Aronna]]></surname>
<given-names><![CDATA[Michael]]></given-names>
</name>
<name>
<surname><![CDATA[Durham]]></surname>
<given-names><![CDATA[José Oviedo]]></given-names>
</name>
</person-group>
<source><![CDATA[The Posmodernism Debate in Latin America]]></source>
<year>1995</year>
<page-range>57-70</page-range><publisher-loc><![CDATA[Durham y Londres ]]></publisher-loc>
<publisher-name><![CDATA[Duke University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Echeverría]]></surname>
<given-names><![CDATA[Bolívar]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El concepto de modernidad]]></article-title>
<source><![CDATA[Discurso crítico y filosofía de la cultura]]></source>
<year>2005</year>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Sistema de salud pública, un problema más para los mexicanos]]></article-title>
<source><![CDATA[Forbes]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Las farmacéuticas disparan ganancias 66% por vacunas contra Covid-19]]></article-title>
<source><![CDATA[Forbes]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Forshery]]></surname>
<given-names><![CDATA[Ellen Mary]]></given-names>
</name>
<name>
<surname><![CDATA[Hansen]]></surname>
<given-names><![CDATA[Anders Braarud]]></given-names>
</name>
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[Hanne Marie]]></given-names>
</name>
<name>
<surname><![CDATA[Olesen]]></surname>
<given-names><![CDATA[Ingrid]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patent Ethics: The Misaligment of Views Between the Patent System and the Wider Society]]></article-title>
<source><![CDATA[Science and Engineering Ethics]]></source>
<year>2018</year>
<volume>24</volume>
<page-range>1551-76</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gebrekidan]]></surname>
<given-names><![CDATA[Selam]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los acuerdos secretos por las vacunas]]></article-title>
<source><![CDATA[The New York Times]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gostin]]></surname>
<given-names><![CDATA[Lawrence]]></given-names>
</name>
<name>
<surname><![CDATA[Abdool]]></surname>
<given-names><![CDATA[Safura]]></given-names>
</name>
<name>
<surname><![CDATA[Mason]]></surname>
<given-names><![CDATA[Benjamin]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Facilitating Access to a COVID-19. Vaccine throug Global Health Law]]></article-title>
<source><![CDATA[Journal of Law, Medicine &amp; Ethics]]></source>
<year>2020</year>
<volume>48</volume>
<page-range>622-6</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grady]]></surname>
<given-names><![CDATA[Christine]]></given-names>
</name>
</person-group>
<source><![CDATA[Ethics of Vaccine Research&#8221;, Nature Publishing Group]]></source>
<year>2004</year>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hassoun]]></surname>
<given-names><![CDATA[Nicole]]></given-names>
</name>
</person-group>
<source><![CDATA[¿Qué es COVAX y por qué será clave en distribución de la vacuna contra el COVID-19 en México?]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herman]]></surname>
<given-names><![CDATA[Bob]]></given-names>
</name>
</person-group>
<source><![CDATA[Moderna Skirts Disclosures of Coronavirus Vaccine Costs]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hooker]]></surname>
<given-names><![CDATA[Lucy]]></given-names>
</name>
<name>
<surname><![CDATA[Palumbo]]></surname>
<given-names><![CDATA[Daniele]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vacunas contra el coronavirus: cuánto dinero pueden ganar realmente las farmacéuticas con la inmunización]]></article-title>
<source><![CDATA[BBC Negocios]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="">
<collab>IMPI (Instituto Mexicano de la Propiedad Industrial)</collab>
<source><![CDATA[]]></source>
<year>1987</year>
</nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="">
<collab>INEGI (Instituto Nacional de Estadística y Geografía)</collab>
<source><![CDATA[Comunicado de prensa núm. 480/20 29 de octubre]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="">
<collab>INEGI (Instituto Nacional de Estadística y Geografía)</collab>
<source><![CDATA[Características de las defunciones registradas en México durante enero a agosto de 2020]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Latour]]></surname>
<given-names><![CDATA[Bruno]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Give Me a Laboratory and I Will Raise the World]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Biagioli]]></surname>
<given-names><![CDATA[Mario]]></given-names>
</name>
</person-group>
<source><![CDATA[The Science Studies Reader]]></source>
<year>1983</year>
<publisher-loc><![CDATA[Nueva York ]]></publisher-loc>
<publisher-name><![CDATA[Routledge]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Qian]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[Hongzhou]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Latest Updates on COVID-19 Vaccines]]></article-title>
<source><![CDATA[BioSciences Trends]]></source>
<year>2020</year>
<volume>14</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>463-6</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arthur]]></surname>
<given-names><![CDATA[Macewan]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Are Governments Economically Stupid in Failing to Suspend Patent Protection for Vaccines?]]></article-title>
<source><![CDATA[Dollars and Sense]]></source>
<year>2021</year>
<volume>33</volume>
<page-range>1-2</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nancy]]></surname>
<given-names><![CDATA[Malacara]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El T-Mec mantendrá precios altos por más tiempo en los medicamentos]]></article-title>
<source><![CDATA[Expansión]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Méndez]]></surname>
<given-names><![CDATA[José Ricardo]]></given-names>
</name>
</person-group>
<source><![CDATA[Las patentes en México a 20 años de la adopción del Acuerdo sobre Aspectos de Propiedad Intelectual Relacionados con el Comercio (ADPIC)]]></source>
<year>2014</year>
<conf-name><![CDATA[ Congreso Internacional de Contaduría, Administración e Informática]]></conf-name>
<conf-loc>Ciudad de México </conf-loc>
</nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Méndez Méndez]]></surname>
<given-names><![CDATA[Judith S.]]></given-names>
</name>
</person-group>
<source><![CDATA[La contracción del gasto per cápita en salud: 2010-2020]]></source>
<year>2021</year>
<publisher-name><![CDATA[Centro de Investigación Económica y Presupuestaria, A.C.]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Del Viagra a luchar contra el covid-19&#8230; ésta es la historia de Pfizer]]></article-title>
<source><![CDATA[Milenio]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="">
<collab>Moderna</collab>
<source><![CDATA[Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program forVaccine (mRNA-1273) Against COVID-19]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="">
<collab>Moderna</collab>
<source><![CDATA[Moderna Announces Supply Agreement with U.S. Government for Initial 100 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monroy]]></surname>
<given-names><![CDATA[Jorge]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Amnistía Internacional pide a México postura sobre liberación de patentes de vacunas Covid-19]]></article-title>
<source><![CDATA[El Financiero]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="">
<collab>OMC (Organización Mundial del Comercio)</collab>
<source><![CDATA[Parte II. Normas relativas a la existencia, alcance y ejercicio de los derechos de propiedad intelectual]]></source>
<year>1994</year>
</nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="">
<collab>OMC (Organización Mundial del Comercio)</collab>
<source><![CDATA[Parte II. Normas relativas a los derechos de propiedad intelectual]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="">
<collab>ONU (Organización de las Naciones Unidas)</collab>
<source><![CDATA[Vacuna AstraZeneca: &#8216;La OMS dice que no hay datos suficientes sobre combinar vacunas distintas contra el COVID-19&#8217;]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<collab>Our World in Data</collab>
<article-title xml:lang=""><![CDATA[Coronavirus (Covid-19) Vaccinations]]></article-title>
<source><![CDATA[Statistics and Research]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="">
<collab>Oxfam</collab>
<source><![CDATA[Patentes contra pacientes]]></source>
<year>2006</year>
</nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[Alice]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[AstraZeneca&#8217;s Vaccine Woes]]></article-title>
<source><![CDATA[Time]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="">
<collab>Pfizer</collab>
<source><![CDATA[Un poco de historia]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="">
<collab>Pfizer</collab>
<source><![CDATA[On of the World´S Premier Biopharmaceutical Companies]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rangel]]></surname>
<given-names><![CDATA[David]]></given-names>
</name>
</person-group>
<source><![CDATA[Derecho de la propiedad industrial e intelectual]]></source>
<year>1992</year>
</nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[Alfonso]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Moderna: científicos que se tornan en multimillonarios por la vacuna&#8221;, CincoDías]]></article-title>
<source><![CDATA[El País]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sachs]]></surname>
<given-names><![CDATA[Rachel E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Uneasy case of Patent Law]]></article-title>
<source><![CDATA[Michigan Law Review]]></source>
<year>2018</year>
<volume>117</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>499-545</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sichelman]]></surname>
<given-names><![CDATA[Ted]]></given-names>
</name>
<name>
<surname><![CDATA[Sean]]></surname>
<given-names><![CDATA[O&#8217;Connor]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patents as Promoters of Competition: The Guild Origins of Patent Law in the Venetian Republic]]></article-title>
<source><![CDATA[San Diego Law Review]]></source>
<year>2012</year>
<volume>49</volume>
<page-range>1267-82</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="">
<collab>Statista</collab>
<source><![CDATA[Número de dosis confirmadas de vacunas contra COVID-19 en México a 19 de marzo de 2021]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="">
<collab>Statista</collab>
<source><![CDATA[México: porcentaje de vacunados contra la Covid-19 2020-2021]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Sputnik V Covid-19 Vaccine Candidate Appears Safe and Effective]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2021</year>
<volume>397</volume>
</nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toledo]]></surname>
<given-names><![CDATA[Víctor]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La vacunación, un triunfo de la ciencia y de la especie]]></article-title>
<source><![CDATA[La Jornada]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Velázquez]]></surname>
<given-names><![CDATA[Germán]]></given-names>
</name>
</person-group>
<source><![CDATA[Pautas de patentabilidad y el acceso a medicamentos]]></source>
<year>2015</year>
<page-range>1-32</page-range><publisher-loc><![CDATA[Centro del Sur Ch ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="">
<collab>WHO (World Healht Organization)</collab>
<source><![CDATA[Coronavirus Disease (COVID-19) Pandemic]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="">
<collab>WIPO (World Intellectual Property Organization)</collab>
<source><![CDATA[Paris Convention for the Protection of Industrial Property]]></source>
<year>1979</year>
</nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="">
<collab>WIPO (World Intellectual Property Organization)</collab>
<source><![CDATA[PCT-El sistema Internacional de Patentes]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="">
<source><![CDATA[AstraZeneca]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="">
<source><![CDATA[BioNTech]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="">
<source><![CDATA[Cansinotech]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="">
<source><![CDATA[El Economista digital]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="">
<source><![CDATA[El Financiero digital]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="">
<source><![CDATA[European Medicines Agency]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="">
<source><![CDATA[Expansión digital]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="">
<source><![CDATA[Forbes]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B63">
<nlm-citation citation-type="">
<source><![CDATA[Pfizer]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B64">
<nlm-citation citation-type="">
<source><![CDATA[Sinovacbio]]></source>
<year></year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
